Destination Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Destination Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$448K	Buy	797 +23	+3%	+$14.7K	0.01%	218
2025 Q4	$524K	Sell	774 -23	-3%	-$15.7K	0.01%	193
2025 Q3	$509K	Buy	797 +12	+2%	+$7.28K	0.01%	179
2025 Q2	$421K	Buy	785 +4	+0.5%	+$1.91K	0.01%	191
2025 Q1	$328K	Buy	781 +8	+1%	+$3.47K	0.01%	198
2024 Q4	$320K	Buy	+773	New	+$339K	0.01%	194
2019 Q2	–	Sell	-3	Closed	-$1K	–	644
2019 Q1	$1K	Buy	+3	New	+$619	﹤0.01%	635
2018 Q2	–	Sell	-14	Closed	-$3K	–	578
2018 Q1	$3K	Buy	+14	New	+$2.58K	﹤0.01%	482

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Destination Wealth Management's IDXX Position: Q1 2026 in Review

Destination Wealth Management increased its Idexx Laboratories (IDXX) stake by 3% in Q1 2026, buying an estimated $14.7K and bringing the position to 797 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #218.

Destination Wealth Management first reported a position in IDXX in Q1 2018 and has held it in 8 quarters since. The position peaked at $524K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Destination Wealth Management held 797 shares of Idexx Laboratories worth $448K as of Q1 2026.
Destination Wealth Management bought 23 Idexx Laboratories shares in Q1 2026, an estimated $14.7K.
Idexx Laboratories made up 0.01% of Destination Wealth Management's portfolio in Q1 2026, its #218 holding.
Destination Wealth Management first reported a position in Idexx Laboratories in Q1 2018 and has held it in 8 quarters since.
Destination Wealth Management's Idexx Laboratories position peaked at $524K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Destination Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.